Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Feb 25

PMID 36836621

Authors

Carmen Rodriguez-Garcia

Francisco Gutierrez-Santiago

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide. Its main modifiable risk factors are diet, alcohol consumption, and smoking. Thus, the right approach through lifestyle changes may lead to its prevention. In fact, some natural dietary components have exhibited chemopreventive activity through modulation of cellular processes involved in CRC development. Although cancer is a multi-factorial process, the study of post-translational modifications (PTMs) of proteins associated with CRC has recently gained interest, as inappropriate modification is closely related to the activation of cell signalling pathways involved in carcinogenesis. Therefore, this review aimed to collect the main PTMs associated with CRC, analyse the relationship between different proteins that are susceptible to inappropriate PTMs, and review the available scientific literature on the role of plant-based dietary compounds in modulating CRC-associated PTMs. In summary, this review suggested that some plant-based dietary components such as phenols, flavonoids, lignans, terpenoids, and alkaloids may be able to correct the inappropriate PTMs associated with CRC and promote apoptosis in tumour cells.

Citing Articles

Molecular Understanding and Pharmacological Potency of Plant-Derived Compounds in Colorectal Cancer (CRC): A Critical Analysis and Future Perspectives.

Mukkavilli V, Ramakrishnan G, Gujjula K, S B, Chamarthy S, Mekala J Cell Biochem Biophys. 2024; 82(3):1777-1795.

PMID: 38965179 DOI: 10.1007/s12013-024-01370-1.

Oils from Transgenic Flax Lines as Potential Chemopreventive Agents in Colorectal Cancer.

Gebarowski T, Wiatrak B, Jeskowiak-Kossakowska I, Grajzer M, Prescha A Biomedicines. 2023; 11(9).

PMID: 37761033 PMC: 10527327. DOI: 10.3390/biomedicines11092592.

Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration.

Brockmueller A, Girisa S, Motallebi M, Kunnumakkara A, Shakibaei M Front Pharmacol. 2023; 14:1203436.

PMID: 37583906 PMC: 10423823. DOI: 10.3389/fphar.2023.1203436.

References

Fini L, Selgrad M, Fogliano V, Graziani G, Romano M, Hotchkiss E . Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr. 2007; 137(12):2622-8. DOI: 10.1093/jn/137.12.2622. View

Cacev T, Aralica G, Loncar B, Kapitanovic S . Loss of NF2/Merlin expression in advanced sporadic colorectal cancer. Cell Oncol (Dordr). 2013; 37(1):69-77. DOI: 10.1007/s13402-013-0164-2. View

Zhao M, Gjerset R . Topoisomerase-I PS506 as a Dual Function Cancer Biomarker. PLoS One. 2015; 10(8):e0134929. PMC: 4527781. DOI: 10.1371/journal.pone.0134929. View

Josse C, Bouznad N, Geurts P, Irrthum A, Huynh-Thu V, Servais L . Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2014; 306(3):G229-43. DOI: 10.1152/ajpgi.00484.2012. View

Uchiyama T, Takahashi H, Sugiyama M, Sakai E, Endo H, Hosono K . Leptin receptor is involved in STAT3 activation in human colorectal adenoma. Cancer Sci. 2010; 102(2):367-72. DOI: 10.1111/j.1349-7006.2010.01803.x. View

Laferriere J, Houle F, Taher M, Valerie K, Huot J . Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem. 2001; 276(36):33762-72. DOI: 10.1074/jbc.M008564200. View

Sularz O, Koronowicz A, Boycott C, Smolen S, Stefanska B . Molecular Effects of Iodine-Biofortified Lettuce in Human Gastrointestinal Cancer Cells. Nutrients. 2022; 14(20). PMC: 9607317. DOI: 10.3390/nu14204287. View

Huang C, Wu D, Lin P, Lee H . Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87. Oncotarget. 2015; 6(11):8698-708. PMC: 4496177. DOI: 10.18632/oncotarget.3537. View

Zhong Y, Krisanapun C, Lee S, Nualsanit T, Sams C, Peungvicha P . Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer. 2010; 46(18):3365-74. PMC: 2988105. DOI: 10.1016/j.ejca.2010.07.007. View

10.

Hernandez Borrero L, El-Deiry W . Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188556. PMC: 8730328. DOI: 10.1016/j.bbcan.2021.188556. View

11.

Kwon Y, Jo H, Bae S, Seo Y, Song P, Song M . Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. Front Med (Lausanne). 2021; 8:747333. PMC: 8492935. DOI: 10.3389/fmed.2021.747333. View

12.

Cristobal I, Manso R, Rincon R, Carames C, Zazo S, Del Pulgar T . Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer. Br J Cancer. 2014; 111(4):756-62. PMC: 4134505. DOI: 10.1038/bjc.2014.376. View

13.

Bartnik M, Slawinska-Brych A, Zurek A, Kandefer-Szerszen M, Zdzisinska B . 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells. J Ethnopharmacol. 2017; 207:19-29. DOI: 10.1016/j.jep.2017.06.010. View

14.

Shibuya M . Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2012; 153(1):13-9. PMC: 3528006. DOI: 10.1093/jb/mvs136. View

15.

Ahmad Hidayat A, Chan C, Mohamad J, Kadir H . Dioscorea bulbifera induced apoptosis through inhibition of ERK 1/2 and activation of JNK signaling pathways in HCT116 human colorectal carcinoma cells. Biomed Pharmacother. 2018; 104:806-816. DOI: 10.1016/j.biopha.2018.05.073. View

16.

Doller A, Winkler C, Azrilian I, Schulz S, Hartmann S, Pfeilschifter J . High-constitutive HuR phosphorylation at Ser 318 by PKC{delta} propagates tumor relevant functions in colon carcinoma cells. Carcinogenesis. 2011; 32(5):676-85. DOI: 10.1093/carcin/bgr024. View

17.

Ren S, Xing Y, Wang C, Jiang F, Liu G, Li Z . Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway. Int J Biochem Cell Biol. 2020; 125:105777. DOI: 10.1016/j.biocel.2020.105777. View

18.

Cho E, Zheng S, Munro S, Liu G, Carr S, Moehlenbrink J . Arginine methylation controls growth regulation by E2F-1. EMBO J. 2012; 31(7):1785-97. PMC: 3321197. DOI: 10.1038/emboj.2012.17. View

19.

Li F, Huang J, Cui M, Zeng J, Li P, Li L . BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells. Oncol Rep. 2020; 43(2):415-426. PMC: 6967201. DOI: 10.3892/or.2019.7427. View

20.

Deng L, Meng T, Chen L, Wei W, Wang P . The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020; 5(1):11. PMC: 7048745. DOI: 10.1038/s41392-020-0107-0. View